Something has quietly shifted in oncology waiting rooms. For decades, a cancer diagnosis before age 50 was the exception – an anomaly that prompted immediate genetic counseling and a search for hereditary causes. Today, doctors describe a different picture. Patients are arriving younger. The average age at diagnosis for certain cancers has dropped by years within a single generation. Clinicians who trained in an era when colorectal cancer was almost exclusively a disease of older adults are now treating it in people in their thirties. And for the scientists trying to understand why, the most consistent clue keeps pointing to one thing.
It’s not a new virus. It’s not a mysterious environmental toxin. It’s a condition so common in wealthy nations that it’s become almost invisible – excess body weight. A major new analysis has given researchers the most granular picture yet of how rising obesity rates among younger adults in England may be fuelling a troubling increase in multiple cancer types. The findings are striking. But as the researchers themselves are careful to note, they are also incomplete. Obesity appears to be the best explanation science currently has. It isn’t the whole story.
Understanding what this research actually shows – and what it doesn’t – matters enormously for anyone thinking about their own cancer risk. The science here is moving fast, and the conclusions carry real implications for how adults in their thirties and forties should think about their health.
The Study: What Researchers Found
Using national cancer registry data in England covering the period 2001 to 2019, researchers from the Cancer Epidemiology and Prevention Research Unit (CEPRU) at the Institute of Cancer Research (ICR) and Imperial College London examined incidence trends across 22 cancer types in women and 21 in men. The study was published in the open-access journal BMJ Oncology.
They identified 11 cancers that are increasing among younger adults aged 20 to 49 and are linked to known behavioral risk factors. Cases of several of those cancers are rising in England among both younger and older adults, but rates of bowel and ovarian cancer are rising only among younger adults. Some other types of cancer are also rising faster in younger adults than in older adults.
With the exception of mouth cancer, all 11 cancers were associated with obesity. Six – liver, bowel, mouth, pancreas, kidney, and ovary – were also linked to smoking. Four – liver, bowel, mouth, and breast – were associated with alcohol intake. Three cancers (bowel, breast, and endometrial) were linked to physical inactivity, and one (bowel) was associated with dietary factors.
But the key finding came when researchers looked at which of these risk factors had actually worsened over time among younger adults. The results showed that trends for most risk factors, except for overweight and obesity, were either stable or improving, making them unlikely to substantially explain recent increases in incidence. Over the past two decades, smoking among younger adults fell by around two percent a year, alcohol consumption mostly stabilized or declined, and physical inactivity decreased.
In contrast, overweight and obesity, which have increased steadily since 1995, were identified by the researchers as key factors. The largest increases in obesity were seen in younger women, with a 2.6 percent relative increase per year since 1995.
The Scale of the Problem in England
The backdrop to this research is England’s own weight crisis. In 2024, 30 percent of adults aged 16 and over were living with obesity, and 66 percent were either overweight or living with obesity. Obesity prevalence increased rapidly between 1993 and 2008, from 15 percent to 25 percent, and has continued more slowly since, reaching 30 percent by 2024. That decades-long creep is precisely the kind of prolonged exposure to excess body weight that researchers believe is now showing up in cancer incidence data for people who were young adults during the 1990s and 2000s.
About 31,000 cancers were recorded in people aged 20 to 49 in England in 2026, with women representing nearly two-thirds of cases – largely because of breast cancer.
Why Obesity Promotes Cancer: The Biological Pathways
Excess body weight is not simply a passive condition. Obesity causes pathological changes to the hormonal and inflammatory environment within the body, which in turn increases the risk of a person developing cancer. Several distinct biological mechanisms have been identified.
The first involves chronic inflammation. People with obesity often have chronic inflammation, which directly promotes tumor growth by several mechanisms. Fat cells produce hormones called adipokines, which can stimulate or inhibit cell growth. Two of these adipokines, leptin and adiponectin, have opposing effects on cancer risk. Obesity not only increases white adipose tissue but also alters the adipocyte endocrine function, reducing adiponectin synthesis and increasing leptin production. These peptide hormones have antagonistic actions regarding cancer development: leptin may act as a growth factor and promotes an inflammatory environment, while adiponectin suppresses cancer cell proliferation.
The second pathway involves insulin resistance and elevated insulin-like growth factor 1 (IGF-1). Obesity-driven cancer risk is linked to hormonal imbalances, including increased estrogen levels that heighten the likelihood of breast and endometrial cancers, and insulin resistance that activates the insulin and IGF-1 pathway, promoting colorectal cancer progression. In plain terms, chronically high insulin levels act like a fertilizer for certain cancer cells, encouraging them to grow and divide unchecked.
A third factor involves sex hormones. Fat tissue in the body converts androgens (male hormones) into estrogen through a process called aromatization. Hormonal changes, particularly elevated estrogen from adipose tissue aromatization and increased leptin levels, fuel the proliferation of hormone-receptor-positive breast cancer cells while reducing the protective effects of adiponectin.
Research published in 2025 by the International Agency for Research on Cancer (IARC) added another dimension. The study revealed that obesity may increase cancer risk even before clinical signs of metabolic or organ dysfunction are detectable, and was the first to apply a revised obesity classification framework in the context of cancer development. The findings indicate that individuals with preclinical obesity already face a significantly elevated cancer risk, even without metabolic abnormalities. Clinical obesity, characterized by both excess body fat and organ dysfunction, was associated with even higher cancer risks, particularly for liver, colorectal, endometrial, pancreatic, and lung cancers. This matters practically: it suggests that waiting for a diabetes diagnosis or elevated blood markers before addressing weight may be waiting too long.
This Is Not Just an England Problem
The pattern researchers identified in England fits a broader international trend. A 2023 study in BMJ Oncology reported that worldwide cancer cases in people under 50 rose 79 percent between 1990 and 2019. The number of cancer deaths increased by 27.7 percent.
In the United States, a separate analysis by researchers at the National Institutes of Health (NIH) published in Cancer Discovery in May 2025 found that the incidence of 14 cancer types had risen among people under age 50, while 19 other cancer types had fallen. The largest absolute increases in early-onset cancers were seen for female breast cancer, with about 4,800 additional cases recorded in 2019 compared to expected rates based on 2010 data, followed by colorectal (2,100), kidney (1,800), uterine (1,200), and pancreatic cancers (500).
The American Cancer Society has documented something particularly stark within this trend. Especially notable is the rise in colorectal cancer among people younger than 50. In the late 1990s, colorectal cancer was the fourth leading cause of cancer death in both men and women under 50. Now, it is the first cause of cancer death in men younger than 50 and the second cause in women that age.
A 2024 report in The Lancet Public Health00156-7/fulltext) found even wider scope to the problem. It identified increasing rates in younger adults in 17 of 34 cancer types examined, including nine that previously had declining incidence in older birth cohorts.
The gender dimension of this trend is also notable. Data from Memorial Sloan Kettering Cancer Center reports that cancer incidence rates in women under 50 are now 82 percent higher than their male counterparts, up from 51 percent in 2002.
For a deeper look at how these trends are playing out specifically for bowel cancer in younger people, see our earlier reporting on early-onset colorectal cancer.
What Obesity Explains – and What It Doesn’t
The researchers behind the England-based analysis are careful to draw a distinction between obesity being a significant factor and it being a complete explanation. The analysis showed that increases in body mass index (BMI) alone are not sufficient to explain the overall rise in cancer incidence, pointing to additional, suspected or currently unknown causes.
Professor Montse Garcia-Closas from the ICR said data suggested around 15 percent of bowel cancer in younger people could be down to being overweight or obese. The study found that increases in BMI alone are not enough to explain the overall rise in cancer among younger adults in England.
Established behavioural risk factors for cancer such as smoking, alcohol use, overweight and obesity, physical inactivity, red and processed meat consumption, and low fibre intake together accounted for an estimated 40 to 50 percent of cases of bowel, endometrial, oral, or liver cancer in 2019. That means a substantial portion of cases remain unexplained even by the full combination of known risk factors.
Several other factors have been proposed as driving the rising incidence, including ultra-processed foods, childhood obesity, physical inactivity, antibiotic use, sweetened drinks, and air pollution. While these factors are common in England, most have shown stable or declining trends in the last decade. Emerging evidence suggests that other obesity-related factors not captured by BMI, including metabolic dysfunction, inflammation, and gut microbiome disruption, may influence bowel cancer risk, but further research is needed.
Genetics, while relevant, also falls short as a standalone explanation. Research presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 found that researchers looking at the prevalence of high-penetrance germline mutations in early-onset cancers found an overall prevalence of these hereditary mutations of 18.4 percent in early-onset cases – meaning around 80 percent of those with early-onset cancer do not have a germline mutation. As one researcher summarised at the same conference, “genetics alone cannot explain the rise that we have seen for early-onset cancers because our genome just doesn’t change so quickly over several decades.”
Most cancers with rates rising in younger adults are also increasing in older adults, suggesting there are common causes between the two age groups. That points away from a purely age-specific trigger and toward generational lifestyle exposures that affect adults broadly, with younger cohorts simply starting the clock earlier.
The Screening Gap
One factor quietly amplifying the impact of this trend is that most people in the 20 to 49 age group fall below recommended screening thresholds. Many individuals in this age group are too young for recommended routine cancer screenings – mammography typically starts at 40 and colonoscopies at 45. Busy lives also make it difficult to keep up with routine primary care visits, where family history might prompt a doctor to suggest earlier screening.
This matters because earlier detection dramatically changes outcomes. For people under 50, colorectal cancer is now the leading cause of cancer death in men and the second in women. Early detection remains crucial, and not enough people are being screened. Among adults aged 40 to 49, 80 percent are not being screened.
The good news is that screening guidelines are beginning to shift in response. The spike in colorectal cancers among younger people led major medical groups to lower the recommended starting age for screening from 50 to 45. Research from the American Cancer Society published in August 2025 found that the new guidelines increased colorectal screening by 62 percent among people between 45 and 50, and the number of colorectal cancer cases diagnosed in that age group jumped from 1 percent to 12 percent. Experts note that is largely positive, as it reflects more cancers being caught at an earlier and more treatable stage.
What the Research Means for Prevention
Obesity causes pathological changes to the hormonal and inflammatory environment within the body, which in turn increases the risk of a person developing cancer. That process does not happen overnight. It unfolds over years of sustained excess weight, and crucially, it is not irreversible. Evidence from bariatric surgery studies demonstrates that meaningful weight loss is associated with a reduction in cancer risk for obesity-related cancer types.
Read More: Early-Onset Colorectal Cancer: What You Should Know
Although increases in cancer in younger adults are concerning, the absolute burden remains far higher in older adults, making it important to study risk factors across all ages. That context doesn’t minimise the trend, but it does help calibrate alarm. The researchers are not describing an epidemic in which cancer has become likely for healthy young adults. They are describing a directional shift that, if left unaddressed, will compound over decades.
The authors say large, long-term studies that can capture exposures across the life course and assess emerging risks are urgently needed to understand what is driving the increase in early-onset cancers. Until those studies report back, the public health implications of the current evidence still point clearly toward one modifiable factor that individuals can act on.
What This Means for You
The convergence of evidence from England, the United States, and international datasets tells a consistent story: cancer in adults under 50 is rising, and excess body weight has emerged as the most consistent modifiable explanation researchers have found. Obesity is not merely a cosmetic or metabolic issue. It changes the internal environment of the body in ways that actively promote tumour development – through chronic inflammation, hormonal disruption, insulin resistance, and altered fat-cell signalling.
What makes this particularly actionable for adults in their thirties and forties is that weight is a modifiable risk factor. Smoking rates are falling. Alcohol consumption is roughly stable. But obesity has continued to rise steadily for three decades among younger adults, and the cancer data is tracking alongside it. In the UK, excess weight and obesity are now the largest modifiable cause of cancer after smoking.
For practical purposes: if you are between 20 and 49, maintaining a healthy weight is among the most evidence-backed steps you can take to reduce your cancer risk. If you have a family history of any of the 11 cancers identified in this research – bowel, ovarian, breast, endometrial, pancreatic, liver, kidney, gallbladder, thyroid, multiple myeloma, or oral – discussing earlier screening with your doctor is warranted, regardless of current guidelines. And if you are in your early-to-mid forties and have never had a bowel cancer screening discussion with a physician, the current evidence suggests that conversation is overdue.
The researchers are right that obesity doesn’t explain everything. But it explains enough – and it’s something that, unlike genetics, can change.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
Read More: Doctor Recommends 7 Foods to Eat More Often as Colon Cancer Rises in Young Adults